These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Suppression of herpes simplex virus infection by antimitotic substances in the rabbit cornea. Tokumaru T; Avitabile A Proc Soc Exp Biol Med; 1971 May; 137(1):29-34. PubMed ID: 4325776 [No Abstract] [Full Text] [Related]
6. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. Chatis PA; Miller CH; Schrager LE; Crumpacker CS N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137 [No Abstract] [Full Text] [Related]
7. Strategies of drug resistance in herpes simplex. Field HJ; Darby GK Nature; 1980 Aug; 286(5776):842. PubMed ID: 6251373 [No Abstract] [Full Text] [Related]
8. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy. Sibrack CD; McLaren C; Barry DW Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725 [TBL] [Abstract][Full Text] [Related]
9. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches. de Clercq E Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935 [No Abstract] [Full Text] [Related]
10. Glucose analogues in the chemotherapy of herpesvirus infections. Blough HA; Ray EK Pharmacol Ther; 1980; 10(3):669-81. PubMed ID: 6255498 [No Abstract] [Full Text] [Related]
11. Resistance of herpes simplex virus to antiviral agents. Is it clinically important? Crumpacker C Drugs; 1983 Nov; 26(5):373-7. PubMed ID: 6315331 [No Abstract] [Full Text] [Related]
12. Brovavir: its antiherpesviral activity and mode of action. Machida H Adv Exp Med Biol; 1990; 278():255-65. PubMed ID: 1963041 [No Abstract] [Full Text] [Related]
13. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo. Rosenwirth B; Griengl H; Wanek E; De Clercq E Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256 [No Abstract] [Full Text] [Related]
14. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice. Allen LB; Hintz OJ; Wolf SM; Huffman JH; Simon LN; Robins RK; Sidwell RW J Infect Dis; 1976 Jun; 133 Suppl():A178-83. PubMed ID: 6598 [TBL] [Abstract][Full Text] [Related]
16. Anti-herpes virus combinations in relation to drug resistance. Hall MJ J Antimicrob Chemother; 1986 Oct; 18 Suppl B():165-76. PubMed ID: 3025155 [TBL] [Abstract][Full Text] [Related]
17. A new topical treatment for resistant herpes simplex infections. Snoeck R; Andrei G; De Clercq E; Gerard M; Clumeck N; Tricot G; Sadzot-Delvaux C N Engl J Med; 1993 Sep; 329(13):968-9. PubMed ID: 8395657 [No Abstract] [Full Text] [Related]
18. Famciclovir/penciclovir. Sacks SL; Wilson B Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386 [No Abstract] [Full Text] [Related]
19. Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice. Weed SD; Stringfellow DA Antiviral Res; 1983 Nov; 3(4):269-74. PubMed ID: 6320719 [TBL] [Abstract][Full Text] [Related]